Pharmiweb.com RSS Feeds 
PharmiWeb Candidate Blog
Press Release
Pharmaceutical R&D Leaders Set To Convene
Pharmaceutical Strategy SeriesPosted on:21 Jan 05
Newton, MA January 13, 2005-On February 9-11, 2005 Cambridge Healthtech Institute
This unique qualified attendance conference is designed to ensure the audience consists of true decision-makers with experience dealing with the strategic issues that face pharmaceutical executives.
The following is a complete list of the leaders presenting at the event:
Dr. Jay Anderson, Eli Lilly and Co., Rick Bayney, Ph.D., Johnson & Johnson, Dr. Matthew Bell, Wyeth Research, Dr. Chris Chamberlain, Roche Products, Dennis Engers, Sanofi-Aventis, Xavier Frapaise, M.D., TAP Pharmaceuticals, Rainer Fuchs, Ph.D., Biogen IDEC
Gianni Gromo, M.D., F. Hoffmann-La Roche Ltd., Dr. Stephen Hutchins, Merck & Co., Charles Jaffe, M.D., Ph.D., AstraZeneca, Shama Kajiji, Pfizer, Inc., Jan-Anders Karlsson, Ph.D., Bayer Healthcare AG, Ismail Kola, Ph.D., Merck Research Laboratories, Michael N. Liebman, Ph.D., Windber Research Institute, Christopher A. Lipinski, Ph.D., Pfizer Global R&D, Jan Malek, PA Consulting Group, Ronald C. Newbold, PhD., Dr. Adrian Otte, Pfizer, Inc., James Resch, Ph.D., AstraZeneca, Robert R. Ruffolo, Ph.D., Wyeth Pharmaceuticals, Wyeth Corporation, Dr. R. Christopher Seaton, Bayer Pharmaceuticals, James B. Summers, Ph.D., Abbott Laboratories, Dr. Wim Swyzen, Johnson & Johnson.
The Pharmaceutical Strategy Series has a proven track record of delivering solution driven presentations that address the most pressing issues confronting R&D leaders. This event brings together best this series has to offer.
About PSS
The Pharmaceutical Strategy Series conferences have been designed to help assess business opportunities and enhance corporate value within the rapidly changing pharmaceutical and biotechnology industries. The PSS Advisory Board is made up of senior level managers at many of the world’s leading pharmaceutical companies including Johnson & Johnson, Merck, Novartis, Eli Lilly, Amgen, AstraZeneca, Aventis and Biogen. The Advisory Board assists in pinpointing exactly the most topical issues to cover and when to cover them. For more details visit www.PharmaSeries.com
About CHI
Cambridge Healthtech Institute is dedicated to producing conferences that service the life science community. Our conferences provide valuable new insights and competing points of view on the very latest developments within the pharmaceutical and biomedical industry. Each year, CHI holds 70 conferences that bring together leaders from their respective discipline. In the past 14 years, CHI has produced over 400 conferences, attracting more than 50,000 attendees from around the world. For more details visit www.healthtech.com
For program related inquiries contact: Jim MacNeil at
To obtain presses pass to this event contact: Lisa Cardinale at
lcardinale@healthtech.comFor a media partnership contact: Jim MacNeil at
jmacneil@healthtech.comFor additional information contact:
Cambridge Healthtech Institute
1037 Chestnut Street
Newton Upper Falls, MA 02464
Tel:617-630-1300
Fax:617-630-1325
Email:chi@healthtech.com
Â
For more information:
http://www.pharmaseries.com
Jim MacNeil
CHI
http://www.pharmaseries.com
617-630-1300
jmacneil@healthtech.com
Last updated on: 27/08/2010 11:40:18
